http://www.biospace.comBioSpace RSS GeneratorThu, 20 Jun 2013 04:16:44 GMT20http://rss.biospace.com/images/BSPLogo.gifhttp://www.BioSpace.com/news.aspx?SectionId=1Copyright (C) 2011http://www.japancorp.net/portal/biospace/index.asp?id=26898Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>Tokyo, June 17, 2013 (JCN Newswire) - Eisai Co., Ltd. announced today that it has decided to further invest at its Hatfield, Hertfordshire production plant in the United Kingdom in creation of an additional...Mon, 17 Jun 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=299397&full=1Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>Nanjing, China June 7, 2013 BASF today announced the opening of its world-scale tert. Butylamine (tBA) production plant at the Nanjing Chemical Industry Park in China. The plant is wholly-owned by BASF and...Thu, 06 Jun 2013 12:00:00 AM GMTStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br><div id"releaseBody"><p>HUDSON, NY and SINGAPORE--(Marketwired - June 04, 2013) - <table class"releaseLink"><tr><td class"releaseLink"><b>Highlighted Links</b></td></tr><tr><td><p>&nbsp;</p><a href...Wed, 05 Jun 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=298615&full=1Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br><div id"releaseBody"><p>SANTIAGO, CHILE--(Marketwired - May 30, 2013) - <b> </b>InVitae Corporation announced today the establishment of a South American subsidiary, InVitae Chile SpA, and a partnership...Fri, 31 May 2013 12:00:00 AM GMThttp://www.reuters.com/article/2013/05/20/us-astrazeneca-cambridge-idUSBRE94J0G120130520Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>AstraZeneca is closing in on a site for its new $500 million home in Cambridge, with a biomedical park just south of the English city the most likely site, property industry sources said. Moving research and...Wed, 22 May 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=297607&full=1Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>Singapore, May 22, 2013 ARKRAY, Inc. has set up its first Asian research center outside Japan in Singapores Institute of Bioengineering and Nanotechnology (IBN). The company will invest $9.1 million over...Wed, 22 May 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=297393&full=1Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br><br><br>21 May 2013: ClinTec International, a global CRO with a presence in over 40 countries worldwide, today announced its intention to formally open an office in Istanbul, Turkey. The office will not only...Tue, 21 May 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=296258&full=1Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>1. Singapore, 10 May 2013 Lloyds Register (LR) and A*STARs Institute of High Performance Computing (IHPC) have officially opened a joint laboratory, which will deliver innovative technological solutions...Fri, 10 May 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=295605&full=1Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>King of Prussia, PA Greenphire, the leading provider of payment technologies for the clinical trials industry, today announced an expansion into the European market with the opening of its London office. ...Tue, 07 May 2013 12:00:00 AM GMThttp://www.globenewswire.com/news-release/2013/05/06/544507/0/en/NeuroSearch-A-S-sells-land-and-building.htmlStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>Today, NeuroSearch (NEUR) signed an agreement with PKA regarding the sale of the company's land and building effective from 1 June 2013 at a cash price of DKK 112.5 million. The agreement is final and unconditional...Mon, 06 May 2013 12:00:00 AM GMThttp://www.independent.co.uk/news/business/news/unions-fight-astra-plans-to-move-rd-base-south-8591975.htmlStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>Union leaders will meet executives at AstraZeneca today to try to convince Britain's second-biggest drugmaker to reverse plans to close its R&D site in Cheshire and move almost 2,000 jobs. AstraZeneca...Tue, 30 Apr 2013 12:00:00 AM GMThttp://www.chinabiotoday.com/articles/20130425Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>April 25, 2013-Eisai Co., Ltd. (Headquarters: Tokyo, President & CEO: Haruo Naito, "Eisai") announced today that it has decided to establish a new parenteral facility (below, "New Plant") on a lot retained...Thu, 25 Apr 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=294223&full=1Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>Morlaix, France - 04/23/2013 HEMARINA, the French based Biotechnology Company, today announced its establishment in Boston, Massachusetts USA thru the incorporation of Hemarina Inc. on March 15th, 201...Wed, 24 Apr 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=294145&full=1Chicago, IL, USA and Glasgow, Scotland, UK, April 23, 2013 / B3C newswire / BioOutsource Ltd. (BioOutsource), a global leader in the biological analysis of biosimilar molecules for the biopharmaceutical industry, today announced the opening of a new facility in Cambridge, Massachusetts, the companys first in the United States. The company plans to draw on its unparalleled depth of experience in...Tue, 23 Apr 2013 12:00:00 AM GMThttp://www.chinabiotoday.com/articles/20130417_2April 16, 2013 -- Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced the opening of its new pharmaceutical manufacturing facility in Hangzhou, China. The facility, located in the Hangzhou Economic and Technology Area (HEDA), will package Merck medicines for China and the Asia Pacific region and will become a critical part of Mercks global supply chain. </p><p>...Thu, 18 Apr 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=293395&full=1Princeton, N.J., April 16, 2013 Covance Inc. (NYSE: CVD), a leading provider of drug development services, today announced completion of the expansion of its central laboratory facility in Singapore to enhance the companys current service offerings and position it to meet current and future growth of drug development in the Asia Pacific region. The expansion is the latest in Covances continued...Tue, 16 Apr 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=293404&full=1<div id"releaseBody"><p>MOSCOW--(Marketwired - April 16, 2013) - Cromos Pharma, an international full service contract research organization (CRO), announced today that it opened an office in the Republic of Georgia.<p>"Georgia is a very important location for Cromos Pharma," noted Dr. Vladimir Bogin, Chief Executive Officer of Cromos Pharma. "Some of the unique qualities of Georgia are...Tue, 16 Apr 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=293391&full=1April 16, 2013 -- The first turf has been cut on Norwich Research Park marking the start of its transformation from a world-class centre of research to a next generation research and innovation park. The new Centrum building will be the hub of the new campus, with meeting spaces to facilitate interaction between commercial and academic researchers, and accommodation for larger commercial organisations...Tue, 16 Apr 2013 12:00:00 AM GMThttp://www.businesswire.com/portal/site/biospace/index.jsp?ndmViewId=news_view&newsId=20130411005567&newsLang=enSINGAPORE & SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Government officials, academic, and industry leaders gathered to celebrate the official opening of the Single-Cell Omics Centre (SCOC) in Singapore today. It is the first research centre in Asia exclusively dedicated to accelerating the understanding of how individual cells work, and how diagnosis and treatment might be enhanced through insight...Fri, 12 Apr 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=292923&full=1HYDERABAD, India--(BUSINESS WIRE)--Dr. Reddys Laboratories (NYSE: RDY) today announced plans to relocate their North America Headquarters and establish a R&D Center in Princeton, New Jersey. Dr. Reddys, represented by Jones Lang LaSalle, has entered into two lease agreements for a 75,500 square foot office facility and a 31,000 square foot office/lab at 107 College Road East and 303 College Road...Wed, 10 Apr 2013 12:00:00 AM GMThttp://www.businesswire.com/portal/site/biospace/index.jsp?ndmViewId=news_view&newsId=20130404005764&newsLang=enPORT WASHINGTON, N.Y.--(BUSINESS WIRE)--Pall Corporation (NYSE:PLL), a global leader in filtration, separation and purification, today confirmed plans for a state-ofthe-art Life Sciences Centre of Excellence at its new Harbourgate site in Portsmouth in the United Kingdom (UK). The Centre of Excellence (COE), which will open in mid 2013, will offer a full suite of capabilities including cell culture...Thu, 04 Apr 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=291663&full=1AUSTIN, Texas and PHILADELPHIA, March 26, 2013 /PRNewswire/ -- GlaxoSmithKline plc (GSK) and The Texas A&M University System announced today that the U.S. Department of Health and Human Services (DHHS) has approved the establishment of a $91 million influenza-vaccines manufacturing facility as the anchor of the Center for Innovation in Advanced Development and Manufacturing (CIADM) in Bryan-College...Wed, 27 Mar 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=291569&full=1Having launched Singapores first bio-analytical laboratory last year, CPR Pharma Services continues to make the Asia-Pacific (APAC) region a global hub for clinical trials by launching its ligand binding assay service for large molecules to complement its existing lab services focused on small molecules.</p><p>The new laboratory, in Adelaide, Australia now offers best practice ligand binding...Tue, 26 Mar 2013 12:00:00 AM GMThttp://www.chinabiotoday.com/articles/20130319by Richard Daverman, PhD</p><p>March 19, 2013 -- Eli Lilly opened the Lilly Global IT Innovations Lab in Dalian yesterday. The lab will provide a platform from which Lilly and its drug development partners in China and across the globe can collaborate freely. Lilly said the Global IT Innovations Lab would support its China investment and its operations globally. More details....</p><p>Stock...Tue, 19 Mar 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=290358&full=1London (13 March 2013) Johnson & Johnson today announced the opening of the Johnson & Johnson Innovation centre in London, one of four regional hubs being established this year in the worlds leading innovation hotspots. A part of Johnson & Johnson Innovation, the goal of the London innovation centre is to accelerate the best early stage science in the world and advance the development of new healthcare...Wed, 13 Mar 2013 12:00:00 AM GMThttp://www.timesofmalta.com/articles/view/20130308/local/Pharmaceutical-firm-to-close-research-unit.460684Pharmaceutical company Actavis has decided to close down the research and development department in Bulebel, where 60 employees work. While insisting that no jobs had been terminated yet, Actavis Maltas managing director, Sergio Vella, explained that, following the acquisition by US giant Watson, the company ended up with many R&D units worldwide, creating duplication of work. Last December, the company...Mon, 11 Mar 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=290125&full=1Cambridge, UK, 11 March 2013: Horizon Discovery (Horizon), a leading provider of research tools to support the development of personalized medicines, today announced it has established two new Centers of Excellence (CoEs) for gene editing in Cambridge, UK. The new Centers are at the Gurdon Institute, Cambridge University with Prof. Steve Jackson FRS, and the Cambridge Institute for Medical Research...Mon, 11 Mar 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=289546&full=1CAMBRIDGE, Mass. / TURKU, Finland March 5, 2013 Finnish company Pharmatest Services Ltd (Pharmatest) announced today that it has opened a new U.S. sales office in Cambridge, Mass., near Boston. The new office, located in the Cambridge Innovation Center (CIC) in Kendall Square, will provide an excellent opportunity for Pharmatest to contact and serve customers in the Massachusetts area.</p><p...Tue, 05 Mar 2013 12:00:00 AM GMThttp://www.saudigazette.com.sa/index.cfm?method=home.regcon&contentid=20130301154956Pfizer Inc., one of the largest pharmaceutical companies in the world, announced Wednesday that it has laid the foundation stone for its drug factory which will be constructed in the King Abdullah Economic City (KAEC), the first in the Gulf region, according to the Saudi Press Agency. The foundation stone was laid during an event held here Wednesday and attended by the secretary general of the Economic...Fri, 01 Mar 2013 12:00:00 AM GMThttp://www.chinabiotoday.com/articles/20130228_2by Richard Daverman, PhD</p><p>February 28, 2013 -- Polaris Group, a San Diego biotech with multinational collaborations, will build a $50 million drug manufacturing facility in Chengdu, the capital of Sichuan Province in Southwest China. Polaris is currently conducting a global Phase III trial of a biotech drug for hepatocellular cancer. Previously, Polaris intended to build the facility in Taiwan...Fri, 01 Mar 2013 12:00:00 AM GMThttp://www.chinabiotoday.com/articles/20130221_1by Richard Daverman, PhD</p><p>February 21, 2013 -- Beijing Double-Crane Pharmaceutical will invest 271 million RMB ($43 million) to build a fluid infusion manufacturing facility in Shanghais Jinshan Development Park. The plant will be operated by a subsidiary of Double-Crane, Shanghai Changzheng Fumin Jinshan Pharmaceutical Co. More details....</p><p>Stock Symbol: (SHE: 600062)</p>Fri, 22 Feb 2013 12:00:00 AM GMThttp://www.chinabiotoday.com/articles/20130205_1by Richard Daverman, PhD and Henry Ye</p><p>February 5, 2013 -- Janssen Pharmaceutical, a division of Johnson & Johnson, has officially opened its China R&D Center in Shanghai Fenglin Life Science Park. The lab is located in the Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences. It will collaborate with the SIOC, Fudan University School of Medicine and other institutions to conduct...Wed, 06 Feb 2013 12:00:00 AM GMThttp://www.bizjournals.com/cincinnati/blog/2013/01/procter-gamble-teva-break-ground.html?ana=otjProcter & Gamble Co. and Israel-based Teva Pharmaceuticals broke ground on a $90 million joint venture facility in the Indian state of Gujarat, the Times of India reported. The plant will make consumer health and over-the-counter products, including inhalers, throat drops and cough syrups under the Vicks brand, in the city of Sanand, as the Business Courier previously reported. The JV company, with...Thu, 31 Jan 2013 12:00:00 AM GMThttp://www.globenewswire.com/news-release/2013/01/30/519418/10019870/en/Pluristem-Takes-Possession-of-and-Moving-Into-New-State-of-the-Art-Manufacturing-Facility.htmlHAIFA, Israel, Jan. 30, 2013 (GLOBE NEWSWIRE) -- Pluristem Therapeutics, Inc. (Nasdaq:PSTI) (TASE:PLTR), a leading developer of placenta-based cell therapies, announced today that the company has taken possession of and is moving into its new state-of-the-art GMP facility. The facility allows for the production of mass quantities of PLacental eXpanded (PLX) cells that possess the advantages of being...Wed, 30 Jan 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=285027&full=1THOUSAND OAKS, Calif.</span>, <span class"xn-chron">Jan. 16, 2013</span> /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced plans to build a new manufacturing facility in the Tuas Biomedical Park area of <span class"xn-location">Singapore</span>. Over the next several years, Amgen anticipates investing approximately <span class"xn-money">$200 million</span> to build an innovative new facility...Thu, 17 Jan 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=284616&full=114th January 2013: Almac is pleased to announce the expansion of our drug product Pharmaceutical Development services with the creation of a new non-GMP formulation development facility and two new analytical laboratories at our UK headquarters in Craigavon. The new facilities double our current pharmaceutical development capacity allowing us to meet the growing demand for our services, both from existing...Mon, 14 Jan 2013 12:00:00 AM GMThttp://www.businesswire.com/portal/site/biospace/index.jsp?ndmViewId=news_view&newsId=20130114005622&newsLang=enMANCHESTER, England--(BUSINESS WIRE)--Oxyrane, a privately-owned biotechnology company with a head office in Manchester, (England) and research operations in Gent, (Belgium), announced today that it has opened a new operation in Burlington, Massachusetts (USA). The new operation is an important step in the companys evolution as it progresses clinical development of its innovative enzyme replacement...Mon, 14 Jan 2013 12:00:00 AM GMThttp://www.wscountytimes.co.uk/news/local/demolition-plans-for-horsham-novartis-site-what-do-you-think-1-4621722The pharmaceutical giant Novartis has published its plans to start redevelopment of its Horsham site. In August the County Times exclusively revealed that the company had decided to sell a significant part of its town campus in Wimblehurst Road, but confirmed its plans to lead world class respiratory research and associated development teams in Horsham. Last week a planning application was submitted...Fri, 28 Dec 2012 12:00:00 AM GMThttp://www.globenewswire.com/news-release/2012/12/27/513598/10016623/en/Pluristem-Initiates-Final-Validation-of-New-Manufacturing-Facility.htmlHAIFA, Israel, Dec. 27, 2012 (GLOBE NEWSWIRE) -- Pluristem Therapeutics, Inc. (Nasdaq:PSTI) (TASE:PLTR), a leading developer of placenta-based cell therapies, announced today it has initiated the final validation steps for its new "state-of-the-art" manufacturing facility prior to taking possession of the facility. These steps include the validation of several installation systems including as heating...Thu, 27 Dec 2012 12:00:00 AM GMThttp://www.chinabiotoday.com/articles/20121226by Richard Daverman, PhD</p><p>December 26, 2012 -- India announced it will locate its own drug inspection office in China in March of 2013, complete with four full-time inspectors. It will be India's first foreign drug office in any country. The Beijing-located operation, which will be in charge of inspecting China manufacturing facilities that export products to India and the medical products...Thu, 27 Dec 2012 12:00:00 AM GMThttp://www.philly.com/philly/business/20121218_Teva_Pharmaceuticals_cancels_plans_for_a_new_complex_in_Northeast_Philadelphia.htmlTeva Pharmaceuticals said Monday night it has decided to cease development plans for its proposed $300 million distribution center in Northeast Philadelphia,At this time we cannot elaborate further about plans for this property, the company said in a prepared statement. Teva (NYSE:TEVA) said it will continue to make the improvements it already committed to along Red Lion Road. Those improvements...Tue, 18 Dec 2012 12:00:00 AM GMThttp://www.business-standard.com/india/news/ranbaxy-to-expand-mohali-unit-to-cater-to-us-market/495690/Ranbaxy Laboratories plans to expand its Mohali facility starting 2014, primarily to meet the increase in demand from the USmarket&select1 target_blank styletext-decoration:none;cursor:hand;>US market. We will look at adding another block at Mohali in 2014 as we have additional land there, Ranbaxys CEO and Managing Director Arun Sawhney told Business Standard. The drug makers existing SEZ ...Mon, 17 Dec 2012 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=282410&full=114 December 2012 -- The Genome Institute of Singapore (GIS), an institute under the umbrella of the Agency for Science, Technology and Research (A*STAR), and Fluidigm Corporation (NASDAQ:FLDM) today announced the establishment of the first research center in Asia exclusively dedicated to accelerating the understanding of how individual cells work, and how diagnosis and treatment might be enhanced through...Fri, 14 Dec 2012 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=282545&full=117 December 2012 -- 1. The LOral Group has opened an Advanced Research Centre in A*STARs Institute of Medical Biology (IMB) to plug into the world-class research environment in Biopolis and Singapore. This is part of LOrals strategy to foster relations with local centres of scientific excellence and internationalize its research to be closer to consumers in support of its strategy to gain one...Thu, 13 Dec 2012 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=282549&full=117 December 2012 -- ZEINCRO, a specialist provider of clinical research services, announces today that it has reinforced its position in Central- and South- Eastern Europe (CSEE), with the opening of offices in 5 additional countries, extending its reach to 14 countries in total.</p><p>In addition to its established presence in Cyprus, Greece, Hungary, Romania and Turkey, ZEINCRO now has offices...Thu, 13 Dec 2012 12:00:00 AM GMThttp://www.chinabiotoday.com/articles/20121208by Richard Daverman, PhD</p><p>December 8, 2012 -- Grupo Insud of Argentina will spend $55 million to build an animal health manufacturing plant in China; Guangzhou Pharma Co. will acquire the assets of Guangzhou Baiyunshan Pharma; Roche opened a sales headquarters in Chengdu to build its Western China revenues; Essex Woodlands, a US growth capital firm, announced a new office in Shanghai to invest...Mon, 10 Dec 2012 12:00:00 AM GMThttp://www.chinabiotoday.com/articles/20121207by Richard Daverman, PhD</p><p>December 6, 2012 -- Essex Woodlands, a US-based growth capital firm that invests only in healthcare companies, has opened an office in Shanghai. The Shanghai office will lead the companys China practice, focusing on pharmaceuticals, medical technology, services, and IT. Essex invests at all stages of development: venture capital, growth equity, PIPEs. In 27 years...Fri, 07 Dec 2012 12:00:00 AM GMThttp://www.chinabiotoday.com/articles/20121207_1by Richard Daverman, PhD</p><p>December 7, 2012 -- Roche has opened a sales headquarters in Chengdu, far away from Eastern provinces where multinational pharmas find their most lucrative markets. The companys West China Management Center is part of Roche's "West Plus" Initiative. Its goal is to double revenues from west China in three years. It is also a bid to expand its R&D in Chengdu and collaborate...Fri, 07 Dec 2012 12:00:00 AM GMThttp://www.thejakartaglobe.com/corporatenews/merck-eyes-indonesia-expansion/559176Pharmaceutical company Merck is counting on Indonesias huge population and accelerating economy to expand its chemical business, a top executive said in Jakarta. Annual sales are expected to grow by 13 to 18 percent next year, after posting double-digit growth in the past few years, said Martin Feulner, director of the chemical division at Merck Indonesia. Merck is a listed company on the Indonesia...Mon, 03 Dec 2012 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=281172&full=14th December 2012: Recipharm has today announced a significant strategic investment to expand capacity in analytical services and stability studies at its facility in Solna, Sweden. The facility is equipped with advanced laboratories and technology for pharmaceutical formulation as well as a GMP suite for development and manufacturing of sterile and non-sterile clinical trial materials. </p><p...Mon, 03 Dec 2012 12:00:00 AM GMThttp://www.chinabiotoday.com/articles/20121129_1by Richard Daverman, PhD</p><p>November 29, 2012 -- TTY Biopharm, a Taiwanese drugmaker, officially opened its new $100 million drug manufacturing facility in Suzhou. The new plant, which will be operated by a subsidiary, TOT Biopharm, will produce injectible drugs that treat cancer. Started as a generic drug company in 1960, TTY now also develops innovative medicines, mainly cancer treatments...Fri, 30 Nov 2012 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=280571&full=1<div id"releaseBody"><p>NEW YORK, NY--(Marketwire - November 26, 2012) - <table class"releaseLink"><tr><td class"releaseLink"><b>Highlighted Links</b></td></tr><tr><td><p>&nbsp;</p><a href"http://www2.marketwire.com/mw/mmframe?prid957731&attachid2161914">Website</a></td></tr><tr><td><p>&nbsp;</p><a href"http://www2.marketwire.com/mw/mmframe?prid957731&attachid2161903">Website</a></td><...Mon, 26 Nov 2012 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=280345&full=1Oxford, UK 20 November 2012 Oxford Gene Technology (OGT), provider of innovative clinical genetics and diagnostic solutions to advance molecular medicine, announced today that it has opened a new office in Tarrytown, New York to support and grow its CytoSure cytogenetics arrays and Genefficiency next generation sequencing business in the US. </p><p>The new office will enable OGT to provide...Tue, 20 Nov 2012 12:00:00 AM GMThttp://www.chinabiotoday.com/articles/20121116_1WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced the official opening of its new facility in Suzhou, China, for the manufacturing of life sciences consumables and equipment. The facility expands the companys global manufacturing footprint and establishes local production capabilities to meet increased customer demand in...Fri, 16 Nov 2012 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=279327&full=1Lundbeck of Denmark, the worlds No.1 neurological pharmaceutical company chose to set up its first Asian factory in Tianjin after selling drugs in China for 16 years. Its another global strategy for Lundbeck, targeting China after the company established a research and development center in Shanghai in 2010. The first phase of investment in this project would be about 6 million, mainly for the production...Mon, 12 Nov 2012 12:00:00 AM GMThttp://www.businesswire.com/portal/site/biospace/template.PAGE/menuitem.ab520ce17e34ab71ff00d635c0908a0c/index.jsp?ndmViewId=news_view&newsId=20121108006857&newsLang=enCAMBRIDGE, Mass.--(BUSINESS WIRE)--Human Metabolome Technologies, Inc. (HMT), the leading developer of capillary electrophoresis mass spectrometry (CE-MS) based metabolomics, today announced the opening of its first U.S. office in Cambridge, Mass. The new office is expected to house up to 20 employees and a laboratory by 2015. HMT is based in Tsuruoka, Japan. Cambridge provides the perfect combination...Fri, 09 Nov 2012 12:00:00 AM GMThttp://www.reuters.com/article/2012/11/04/sanofi-headquarters-idUSL5E8M45E420121104Sanofi's management considered moving its headquarters abroad in the last few months but the plan was nixed by the drugmaker's chairman, French weekly Le Journal du Dimanche reported on Sunday, citing sources close to the board. First mooted in July, when the Socialist government was preparing to introduce a 75 percent tax on top earnings, the plan envisaged moving the headquarters to London or the...Mon, 05 Nov 2012 12:00:00 AM GMThttp://www.chinabiotoday.com/articles/20121101_2November 1, 2012 -- Innovent Biologics, a Suzhou company formed last year, is building a biotech plant in BioBay. The company has two aims: it intends to in-license biotech drugs for the China market, and it also wants to provide contract manufacturing services to other companies. The company is led by an international management team of experienced biotech executives. With $30 million in startup capital...Fri, 02 Nov 2012 12:00:00 AM GMThttp://www.straitstimes.com/breaking-news/money/story/novartis-spend-over-us500m-new-biotechnology-plant-tuas-20121031<a href"http://www.biospace.com/company_profile.aspx?CompanyId1340&typepartner&sourceNewsStoryProfile"><b>Novartis Pharmaceuticals</b></a> | <a href"http://www.biospace.com/jobs/search-results/CustomerId209270?typepartner&sourceNewsStoryJobs"><b>Jobs at Novartis Pharmaceuticals</b></a><br><br><a href"http://www.biospace.com/company_profile.aspx?CompanyId1002633&typepartner&source...Wed, 31 Oct 2012 12:00:00 AM GMThttp://www.smetimes.in/smetimes/news/global-business/2012/Oct/18/mexican-pharmaceutical-maker-buys-pfizer-plant891228.htmlMexican pharmaceutical maker Neolpharma bought a Pfizer facility in Puerto Rico that was set to close at the end of this year, a media report said. Neither party disclosed the value of the transaction, El Nuevo Dia newspaper said. The US giant announced in May 2010 that it would be closing two of its five factories in Puerto Rico, including the 130,000 sq. meter facility in the San Juan suburb of Caguas...Thu, 18 Oct 2012 12:00:00 AM GMThttp://www.chinabiotoday.com/articles/20121016by Richard Daverman, Editor</p><p>October 16, 2012 -- WuXi AppTech has officially opened its GMP manufacturing facility for biologic drugs the first such facility in China compliant with GMP standards in China, the US and Europe. WuXi has constructed a facility that is state-of-the-art, including the first operation anywhere in the globe that uses 100% disposable equipment for producing biologics...Wed, 17 Oct 2012 12:00:00 AM GMThttp://www.globes.co.il/serveen/globes/docview.asp?did=1000789657&fid=1725Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) has opened a new plant in Hungary. The $110 million plant in Godollo, is one of the largest sterile medicines plants in the world. The plant has an annual production capacity of 160-200 million units of injectables - mainly cytotoxics, which are used in oncology therapeutics. Its six production lines can produce six different products simultaneously...Mon, 15 Oct 2012 12:00:00 AM GMThttp://www.chinabiotoday.com/articles/20121011by Richard Daverman, PhD</p><p>October 10, 2012 -- Tianyin Pharmaceuticals reported that its new production facility, which will cost $25 million, is on track to be completed early next year. Tianyin was forced to move two of its plants by the Chengdu municipal government, which designates particular areas for specific industries. Tianyin will combine its pre-extraction and formulation operations...Thu, 11 Oct 2012 12:00:00 AM GMThttp://www.thejakartapost.com/news/2012/10/10/merck-invests-21m-east-java-factory.htmlAmerican pharmaceutical giant Merck Sharp and Dohme (MSD) opened its new packaging factory, worth US$21 million, in Pandaan, Pasuruan, East Java, on Tuesday. The 4,900 square-meter factory will produce packages for medicines in relation to infections, cardiovascular issues, hypertension, respiratory issues, oncology and diabetic issues. Asia Pacific MSD president Patrick Bergstedt said at the factory...Wed, 10 Oct 2012 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=275474&full=1October 09, 2012 -- In response to client requirements, Almacs expansion of their API manufacturing facility at its European Headquarters in Craigavon, UK is near completion, and will be operational by the end of the year. This upgrade includes installation of two 1,000L reactors and state-of-the-art pressure filter dryer, which allows production of GMP Active Pharmaceutical Ingredients (API) up...Tue, 09 Oct 2012 12:00:00 AM GMThttp://www.chinabiotoday.com/articles/20121003by Richard Daverman, PhD</p><p>October 3, 2012 -- QPS Holdings, an international CRO based in the US, has opened an office in Beijing from which it will offer clinical-stage services. The new office will be part of QPS Qualitix, a QPS majority-owned subsidiary that already has facilities in Taiwan and India. According to QPS Qualitix, it has been operating in China through partners. Building on...Wed, 03 Oct 2012 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=274752&full=1Cambridgeshire, UK, 2 October 2012 Quotient Bioresearch (Quotient), the leading provider of early stage and specialist drug development services, has today announced the completion of a 1.5m expansion to its Fordham, Cambridgeshire site. </p><p>The building work took place over the summer and included a new bioanalytical facility with a capacity for 30 mass spectrometers and new laboratories...Tue, 02 Oct 2012 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=274674&full=1SCHAFFHAUSEN, Switzerland Ashland Specialty Ingredients (ASI), a commercial unit of Ashland Inc. (NYSE: ASH), today announced plans to open a new pharmaceutical application laboratory in Dsseldorf, Germany, in December 2012. The laboratory will provide high-level technical support to Ashlands European pharmaceutical and nutraceutical customers.</p><p>With a location central to major pharmaceutical...Mon, 01 Oct 2012 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=274438&full=1LACHEN, Switzerland--(BUSINESS WIRE)-- Octapharma AG today announces the opening of a 25 million research facility dedicated to recombinant protein drug development in Heidelberg, Germany. Octapharma Biopharmaceuticals GmbH is a subsidiary of Octapharma AG, one of the worlds largest providers of human therapeutic proteins and one of the first companies using recombinant technology from human cells...Fri, 28 Sep 2012 12:00:00 AM GMThttp://www.property-magazine.eu/bayer-signs-lease-agreement-in-gda-sk-22502.htmlBayer has decided to locate its new Finance and Accounting Center in Gdansk, in the Olivia Business Centre (OBC). Jones Lang LaSalle has supported the entire process of searching for location in Poland, as well as negotiating the lease agreement. The process of launching the new centre and employee recruitment will have been completed by the end of 2012. In the long term, the company will occupy around...Tue, 25 Sep 2012 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=274105&full=1TARRYTOWN, NY, September 24, 2012 -- BASF announced the opening of a new global dermatology laboratory at 500 White Plains Road in Tarrytown NY. The lab will focus on topical formulations for the pharmaceutical market. Work will include basic research on skin irritation and allergy reactions to full formulations using BASF solubilizers and its broadened excipient portfolio. The laboratory...Tue, 25 Sep 2012 12:00:00 AM GMThttp://www.nytimes.com/2012/09/20/nyregion/roche-swiss-pharmaceutical-giant-to-open-research-center-in-manhattan.html?_r=0What New Jersey loses, New York City gains, at least in part. Roche, the Swiss pharmaceutical giant, will open a new research center in Manhattan that will take on some of the former responsibilities of its big campus in Nutley, N.J. Roche announced in June that it would shut the Nutley site, where the tranquilizer Valium was invented more than 50 years ago, as part of a cost-cutting effort that would...Fri, 21 Sep 2012 12:00:00 AM GMTwww.chinabiotoday.com/articles/20120919NEW BRUNSWICK, N.J.</span>, <span class"xn-chron">Sept. 18, 2012</span> /PRNewswire/ -- Johnson &amp; Johnson today announced plans to establish four regional innovation centers in major life sciences communities in the world as part of a novel approach to accelerate early innovation and enhance opportunities for collaboration and investment across its global healthcare businesses. </p><p>Targeted...Wed, 19 Sep 2012 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=273308&full=1Oslo, Norway, 18 September 2012 - Algeta ASA (OSE: ALGETA), a company focused on the development of novel targeted cancer therapeutics, today celebrates the official opening of the offices and facilities of Algeta US in Cambridge, Massachusetts. </p><p>Jeff Albers, President Algeta US, and senior management colleagues will be joined by local leaders including, Lieutenant...Tue, 18 Sep 2012 12:00:00 AM GMThttp://www.thepharmaletter.com/file/116466/ranbaxy-gains-approval-for-new-manufacturing-plant-in-malaysia.htmlDrug major Ranbaxy Laboratories today said it has received approval from Malaysian authorities to set up its second manufacturing plant in the country at an investment of USD 40 million (around Rs 220 crore). Ranbaxy Malaysia Sdn Bhd, a subsidiary of Ranbaxy Laboratories, received approval for setting up a greenfield manufacturing facility in Malaysia as an EPP (Entry Point Project), the company said...Fri, 14 Sep 2012 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=272804&full=1Goettingen | Guxhagen, Germany, September 12, 2012 / B3C newswire / - Today on Wednesday, Sartorius, the Goettingen-based laboratory and pharmaceutical supplier, formally opened its new plant in Guxhagen in northern Hesse for the manufacture of bioreactors. After approximately one year of construction, the new building was officially dedicated in the presence of the prime minister of the state government...Wed, 12 Sep 2012 12:00:00 AM GMThttp://www.inpharm.com/news/174375/takeda-opens-russian-manufacturing-facilityZURICH, September 11, 2012 /PRNewswire/ --</p><p>State-of-the-art facility in Yaroslavl demonstrates Takeda's long-term commitment to the Russian market</p><p>Plant expected to be fully operational in 2014, supplying high quality tablet and sterile liquid products for the local market</p><p>75 million investment</p><p>Takeda Pharmaceutical International GmbH ("Takeda") today announced...Tue, 11 Sep 2012 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=272536&full=1Dublin, Ireland, 10 September 2012 - ICON plc (NASDAQ: ICLR; ISIN:IE0005711209), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced the expansion of its US and UK bioanalytical facilities to meet the growing demand for biomarker and cell-based assay services.</p><p>ICON has increased its bioanalytical laboratories...Mon, 10 Sep 2012 12:00:00 AM GMT<div id"releaseBody"><p>MOSCOW--(Marketwire - September 05, 2012) - <table class"releaseLink"><tr><td class"releaseLink"><b>Highlighted Links</b></td></tr><tr><td><p>&nbsp;</p><a href"http://www2.marketwire.com/mw/mmframe?prid926703&attachid2083634">COREX pharmaceutical depot in Moscow, Russia</a></td></tr><tr><td><p>&nbsp;</p><a href"http://www2.marketwire.com/mw/mmframe?prid926703&attachid...Wed, 05 Sep 2012 12:00:00 AM GMThttp://www.irishtimes.com/newspaper/finance/2012/0823/1224322766583.htmlNovartis AG (NOVN), Europes largest drugmaker by revenue, is looking for office space in Dublin and may lease an additional 100,000 square feet (9,300 square meters), two people with knowledge of the matter said. IDA Ireland, the government agency that seeks overseas investment, is working with Novartis, said the people, who asked not to be named because the company hasnt yet decided whether to expand...Thu, 23 Aug 2012 12:00:00 AM GMT